Compare AKBA & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AKBA | NECB |
|---|---|---|
| Founded | 2007 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.0M | 344.8M |
| IPO Year | 2014 | 2021 |
| Metric | AKBA | NECB |
|---|---|---|
| Price | $1.40 | $24.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.25 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 2.2M | 32.4K |
| Earning Date | 05-07-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | ★ 93.94 | N/A |
| EPS | N/A | ★ 3.25 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | ★ N/A | $7.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.14 | $19.27 |
| 52 Week High | $4.08 | $25.65 |
| Indicator | AKBA | NECB |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 50.38 |
| Support Level | $1.30 | $22.47 |
| Resistance Level | $1.56 | $25.42 |
| Average True Range (ATR) | 0.08 | 0.62 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 33.90 | 39.82 |
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.